Achieve Life Sciences (ACHV) PT Lowered to $17 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts ACHV Hot Sheet
Price: $7.19 --0%
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 25 | New: 0
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 25 | New: 0
Join SI Premium – FREE
Oppenheimer analyst Francois Brisebois lowered the price target on Achieve Life Sciences (NASDAQ: ACHV) to $17.00 (from $20.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Asian Paints (APNT:IN) PT Raised to INR1,925 at CLSA
- Pidilite Industries Ltd (PIDI:IN) PT Lowered to INR1,680 at Kotak
- Eli Lilly (LLY) PT Raised to $1,650 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
